Related Experiment Video
Updated: Aug 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
The lipids of Pneumocystis carinii
1Department of Biological Sciences, University of Cincinnati, Ohio 45221, USA. Edna.Kaneshiro@uc.edu
Abstract:
Information about a number of Pneumocystis carinii lipids obtained by the analyses of organisms isolated and purified from infected lungs of corticosteroid-immunosuppressed rats has been reported in recent years. Of the common opportunistic protists associated with AIDS (Cryptosporidium, Toxoplasma, and the microsporidia), more is currently known about the lipids of P. carinii than the others. Lipids that are synthesized by the organism but not by humans are attractive targets for drug development. Thus, the elucidation of delta 7C-24-alykylated sterol and cis-9,10-epoxystearic acid biosyntheses in P. carinii is currently being examined in detail, since these have been identified as P. carinii-specific lipids. The development of low-toxicity drugs that prevent sterol C-24 alkylation and the specific inhibition of the lipoxygenase that forms cis-9,10-epoxystearic acid might prove fruitful. Although humans can synthesize coenzyme Q10, the anti-P. carinii activity and low toxicity of ubiquinone analogs such as atovaquone suggest that the electron transport chain in the pathogen may differ importantly from that in the host. Although resistance to atovaquone has been observed, development of other naphthoquinone drugs would provide a broader armamentarium of drugs to treat patients with P. carinii pneumonia. Studies of bronchoalveolar lavage fluid and of infected lungs have demonstrated that the infection causes a number of chemical abnormalities. Bronchoalveolar lavage fluid obtained after the removal of lung cellular material and the organisms has been shown to contain larger amounts of surfactant proteins and smaller amounts of phospholipids than do comparable samples from P. carinii-free lungs. Increased phospholipase activity, inhibition of surfactant secretion by type II cells, and uptake and catabolism of lipids by the pathogen may explain this phenomenon related to P. carinii pneumonia. Although not yet thoroughly examined, initial studies on the uptake and metabolism of lipids by P. carinii suggest that the organism relies heavily on exogenous lipid nutrients.
Insights
Pneumocystis carinii lipids offer drug targets. Research identifies specific P. carinii lipids and metabolic pathways, aiding in developing new treatments for P. carinii pneumonia.
Area of Science:
- Medical Mycology
- Biochemistry
- Drug Discovery
Background:
- Pneumocystis carinii is an opportunistic pathogen often associated with AIDS.
- Lipids unique to P. carinii are potential targets for novel drug development.
- Understanding P. carinii lipid metabolism is crucial for treating P. carinii pneumonia.
Purpose of the Study:
- To investigate P. carinii-specific lipids and their biosynthetic pathways.
- To explore the potential of targeting P. carinii lipid synthesis for therapeutic intervention.
- To understand the biochemical abnormalities in the lungs caused by P. carinii infection.
Main Methods:
- Analysis of lipids from purified P. carinii organisms isolated from infected rat lungs.
- Examination of delta 7C-24-alykylated sterol and cis-9,10-epoxystearic acid biosynthesis.
- Study of bronchoalveolar lavage fluid and infected lung tissue chemistry.
Main Results:
- P. carinii synthesizes unique lipids, including delta 7C-24-alykylated sterols and cis-9,10-epoxystearic acid.
- Atovaquone's efficacy suggests differences in the pathogen's electron transport chain.
- P. carinii infection alters lung surfactant proteins and phospholipids, potentially due to phospholipase activity and pathogen lipid uptake.
Conclusions:
- P. carinii lipids represent promising targets for developing new anti-Pneumocystis drugs.
- Inhibiting specific lipid biosynthetic pathways, like sterol alkylation, may yield effective treatments.
- Further research into P. carinii's reliance on exogenous lipids could reveal new therapeutic strategies.
Related Concept Videos
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Asymmetric Lipid Bilayer
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia I: Introduction

